Last updated: December 7, 2020
Sponsor: University of Florida
Overall Status: Trial Not Available
Phase
N/A
Condition
Renal Failure
Kidney Disease
Nephropathy
Treatment
N/AClinical Study ID
NCT02598674
IRB201500264
Ages 7-17 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: For all patients:
- Ability to assent (age 7-17 at time of participation in the study)
- If taking antihypertensive medication, prescribing practitioner's written approval toparticipate For sAKI patients:
- Hospitalization with a diagnosis of sepsis from 1998-2014
- Severe AKI as defined by the pEDRIFLE criteria during incident sepsis admission
- Participation in cognitive survey study with completion of the PedsQL survey For healthy control patients:
• Patients from the neurology service undergoing MRI with gadolinium as a part of theirclinical care
Exclusion
Exclusion Criteria: For all patients:
- Known pre-existing CKD as defined by history of kidney transplant or long-termdialysis
- Age greater than 17 years at the time of incident sepsis admission
- AKI from primary kidney disease including acute glomerulonephritis and obstructiveuropathy
- Pregnancy at the time of enrollment
- Known or suspected allergy to gadolinium based contrast
- Known or suspected allergy to iodohippurate will be excluded from RPF measurement withiodohippurate
- Heart failure or condition whereby the administration of 0.9% normal saline would becontraindicated
- If taking antihypertensive medication, lack of prescribing practitioner's writtenapproval to participate For healthy control patients:
- Chronic kidney disease
- History of acute kidney injury or GFR <100 History of chronic illnesses deemed topredispose to renal or cardiovascular dysfunction or abnormalities Suspicion ofinfection
- Neuro-vascular history such as encephalitis, meningitis, vascular anomalies of thebrain or spinal cord or cerebrovascular infarct or ischemia will be excluded .
- No indication for gadolinium administration for MRI
Study Design
Study Start date:
October 01, 2019
Estimated Completion Date:
September 30, 2021
Study Description
Connect with a study center
UF Health
Gainesville, Florida 32608
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.